COMMUNIQUÉS West-GlobeNewswire
-
Aeterna Zentaris Announces Details Regarding Transaction with Ceapro
17/05/2024 - 14:00 -
Recce Pharmaceuticals Doses First Participants in Next Cohort of Phase I/II Urinary Tract Infections and Urosepsis Rapid Infusion Clinical Trial
17/05/2024 - 14:00 -
Spectral AI Announces Purchases of Over 100,000 Shares by Insiders
17/05/2024 - 14:00 -
Achieve Life Sciences Announces Data from Cytisinicline ORCA-V1 Program to be Presented at Society of General Internal Medicine (SGIM) Annual Meeting
17/05/2024 - 14:00 -
Femasys CEO and Founder Kathy Lee-Sepsick Meets with the White House’s Office of Science and Technology Policy to Discuss the Cancer Moonshot Initiative
17/05/2024 - 14:30 -
Innovative Fingerprint Drug Screening Solution Showcased at the UK's Premier Health and Safety Event
17/05/2024 - 14:30 -
Assertio to Participate in Benchmark Healthcare Conference on May 21-22
17/05/2024 - 15:15 -
Philips presents study results at Heart Rhythm Annual Meeting demonstrating benefits of its AI-powered cardiac monitoring solutions
17/05/2024 - 10:00 -
Notification of managers’ transactions
17/05/2024 - 11:10 -
Trading by management and close relations of management
17/05/2024 - 12:39 -
QuTEM Receives GMP Certificates and Manufacturing Permits for Transmission Electron Microscopy Laboratory from the Swedish Medical Products Agency
17/05/2024 - 08:00 -
HUTCHMED Highlights Sovleplenib Phase III ESLIM-01 Study and Hematological Malignancy Programs Data to be Presented at the upcoming EHA2024 Congress
17/05/2024 - 02:00 -
Erasca Announces Pricing of Underwritten Offering of Common Stock
17/05/2024 - 02:00 -
Erasca Announces Strategic In-Licensing of RAS-Targeting Franchise
17/05/2024 - 02:02 -
Inventiva annonce la recommandation positive du quatrième DMC de l’étude clinique NATiV3 Phase III avec lanifibranor dans la MASH/NASH
16/05/2024 - 22:00 -
Inventiva announces the positive recommendation of the fourth DMC of the NATiV3 Phase III clinical trial with lanifibranor in patients with MASH/NASH
16/05/2024 - 22:00 -
Galapagos creates new subscription right plans
16/05/2024 - 22:01 -
Evoke Pharma to Present Additional GIMOTI Healthcare Utilization Data Focused on Gastroparesis Care Insights in Women at 2024 Digestive Disease Week (DDW) Conference
16/05/2024 - 22:02 -
ArriVent Appoints John Hohneker, M.D., to its Board of Directors
16/05/2024 - 22:05
Pages